Stephanie Malveira (@smalveira23) 's Twitter Profile
Stephanie Malveira

@smalveira23

Commercial Hematology, Pfizer | Tweets are my own

ID: 1125437852836175874

calendar_today06-05-2019 16:31:08

326 Tweet

189 Takipçi

363 Takip Edilen

Nina Shah (@ninashah33) 's Twitter Profile Photo

The “Backstreet Boys” vs “NSync” of #meloma debates: quads v triplets by Krina Patel & Sagar Lonial MD Most hilarious debate evah! Love Krina’s quotes of Sagar to make her case #DAVAWhistler2022 DAVA Oncology-OMI #mmsm

The “Backstreet Boys” vs “NSync” of #meloma debates: quads v triplets by <a href="/DrKrinaPatel/">Krina Patel</a> &amp; <a href="/SagarLonialMD/">Sagar Lonial MD</a>   Most hilarious debate evah! Love Krina’s quotes of Sagar to make her case #DAVAWhistler2022 <a href="/OMIonc/">DAVA Oncology-OMI</a> #mmsm
Zahra M, PharmD, MBA, BCOP, FHOPA (@kczmj) 's Twitter Profile Photo

Having ASTCT #Tandem22 in the same conference center as a fitness competition has been… interesting… i feel overdressed and a little fluffy….but I still ate a cookie (maybe 3🤫) #YOLO

Having <a href="/ASTCT/">ASTCT</a> #Tandem22 in the same conference center as a fitness competition has been… interesting… i feel overdressed and a little fluffy….but I still ate a cookie (maybe 3🤫) #YOLO
Ajay Major, MD, MBA (@majorajay) 's Twitter Profile Photo

The study we've all been waiting for! ECHELON-1 trial RCT results. BV-AVD demonstrated a significant OS benefit over ABVD (94% vs 89%) at over 6 years of follow up. Time to duke it out, #lymsm! #ASCO22

The study we've all been waiting for! ECHELON-1 trial RCT results. BV-AVD demonstrated a significant OS benefit over ABVD (94% vs 89%) at over 6 years of follow up. Time to duke it out, #lymsm! #ASCO22
Jonathan Friedberg (@drjfriedberg) 's Twitter Profile Photo

Dr Ansell presents OS benefit to AVD brentuximab in pts with advanced HL compared to ABVD. #asco Affirms control group in ⁦SWOG Cancer Research Network⁩ S1826 which is open throughout NCTN.

Dr Ansell presents OS benefit to AVD brentuximab in pts with advanced HL compared to ABVD. #asco Affirms control group in ⁦<a href="/SWOG/">SWOG Cancer Research Network</a>⁩ S1826 which is open throughout NCTN.
Ajay Major, MD, MBA (@majorajay) 's Twitter Profile Photo

Less deaths from HL, tx complications, or SPMs in BV-AVD arm. Much higher neuropathy with BV-AVD; I wish PROs were reported (Grade 1-2 CTCAE neuropathy can profoundly affect QOL despite 'low grade'). #ASCO22 #MajorPROsASCO

Less deaths from HL, tx complications, or SPMs in BV-AVD arm. Much higher neuropathy with BV-AVD; I wish PROs were reported (Grade 1-2 CTCAE neuropathy can profoundly affect QOL despite 'low grade'). #ASCO22 #MajorPROsASCO
Andrew M. Evens, DO, MBA, MSc (@draevens) 's Twitter Profile Photo

Altogether, a significant advance in the field (ie, OS advantage over classic ABVD, etc) and a truly landmark study. 🙌 Kudo's Mayo Clinic Comprehensive Cancer Center Steve Ansell, The Christie NHS John Radford, BC Cancer Joe Connors, Memorial Sloan Kettering Cancer Center David Straus, and all! #ASCO22 #lymphoma #lymsm

Andrew M. Evens, DO, MBA, MSc (@draevens) 's Twitter Profile Photo

Possible but unlikely to make difference (2nd solid tumors same in arms; more heme malig. in ABVD). May be d/t increased relapses/more subsequent Rx etc in ABVD arm. Also, could adcetris have provided a protective effect? 👉BOTTOM LINE: was 41% risk reduction of death w/ A+AVD.

Andrew M. Evens, DO, MBA, MSc (@draevens) 's Twitter Profile Photo

Supplemental data/table below re: above 2nd cancer comment. And we cannot gloss over that there were excess/more deaths seen in ABVD arm due to relapsed disease-Hodgkin #lymphoma. #lymsm

Supplemental data/table below re: above 2nd cancer comment.

And we cannot gloss over that there were excess/more deaths seen in ABVD arm due to relapsed disease-Hodgkin #lymphoma.

#lymsm
Sigma Sreedharan (@sigmas) 's Twitter Profile Photo

#BlueAngels sure keep us on our toes. They changed their path and routines again. Today they went over the city on their return and I got a better shot of them with the #SpaceNeedle. #Seattle #Seafair2022

#BlueAngels sure keep us on our toes. They changed their path and routines again. Today they went over the city on their return and I got a better shot of them with the #SpaceNeedle. #Seattle #Seafair2022
Eddie Cliff (@eddie_cliff) 's Twitter Profile Photo

Incredible to have such an all-star cast of Women in Lymphoma - [email protected] all together celebrating progress & calling for change Career development, from 3 legends of lymphoma: onlinelibrary.wiley.com/doi/10.1002/ho… Reminding the obvious: onlinelibrary.wiley.com/doi/10.1002/ho… #17ICML International Conference on Malignant Lymphoma

Incredible to have such an all-star cast of <a href="/WomenInLymphoma/">Women in Lymphoma - wil@lymphoma.org.au</a> all together celebrating progress &amp; calling for change 

Career development, from 3 legends of lymphoma:
onlinelibrary.wiley.com/doi/10.1002/ho…

Reminding the obvious:  
onlinelibrary.wiley.com/doi/10.1002/ho…

#17ICML <a href="/icmlugano/">International Conference on Malignant Lymphoma</a>
Stephanie Malveira (@smalveira23) 's Twitter Profile Photo

It is an inspiration to read posts on #WorldCancerDay. The journey is complex and lifelong for all of those involved. I am grateful every day for the team at BIDMC that cured my Hodgkin lymphoma 13 years ago, but particularly appreciative on this day every year.

It is an inspiration to read posts on #WorldCancerDay. The journey is complex and lifelong for all of those involved. I am grateful every day for the team at <a href="/BIDMChealth/">BIDMC</a> that cured my Hodgkin lymphoma 13 years ago, but particularly appreciative on this day every year.